Testing effectiveness (Phase 2)Study completedNCT02649218
What this trial is testing
A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients
Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 226